Rose Bengal Photodynamic Therapy (RB-PDT) Modulates the Inflammatory Response in LPS-Stimulated Human Corneal Fibroblasts By Influencing NF-κB and p38 MAPK Signaling Pathways

References

• Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678–1689. doi: 10.1016/j.ophtha.2017.05.012.
   PubMed Web of Science ®Google Scholar
• Sepulveda-Beltran PA, Levine H, Altamirano DS, Martinez JD, Durkee H, Mintz K, Leblanc R, Tóthová JDA, Miller D, Parel JM, et al. Rose bengal photodynamic antimicrobial therapy: a review of the intermediate-term clinical and surgical outcomes. Am J Ophthalmol. 2022;243:125–134. doi: 10.1016/j.ajo.2022.08.004.
   PubMed Web of Science ®Google Scholar
• Wang L, Yang H, Sun Y, Yu FSX, Wu X. Signaling mechanism for Aspergillus fumigatus tolerance in corneal fibroblasts induced by LPS pretreatment. Innate Immun. 2014;20(6):563–573. doi: 10.1177/1753425913502098.
   PubMed Web of Science ®Google Scholar
• Wu D, Lim DKA, Lim BXH, Wong N, Hafezi F, Manotosh R, Lim CHL. Corneal cross-linking: the evolution of treatment for corneal diseases. Front Pharmacol. 2021;12(July):686630. doi: 10.3389/fphar.2021.686630.
   PubMedGoogle Scholar
• Espana EM, Birk DE. Composition, structure and function of the corneal stroma. Exp Eye Res. 2020;198:108137. doi: 10.1016/j.exer.2020.108137.
   PubMed Web of Science ®Google Scholar
• Zhu S, Xu X, Liu K, Gu Q, Wei F, Jin H. Peptide GC31 inhibits chemokines and ICAM-1 expression in corneal fibroblasts exposed to LPS or poly(I: c) by blocking the NF-κB and MAPK pathways. Exp Eye Res. 2017;164:109–117. doi: 10.1016/j.exer.2017.07.017.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Ishida W, Fukushima A, Nishida T. Corneal fibroblasts as sentinel cells and local immune modulators in infectious keratitis. Int J Mol Sci. 2017;18(9):1831. doi: 10.3390/ijms18091831.
   PubMed Web of Science ®Google Scholar
• Garcia-Vello P, Di Lorenzo F, Zucchetta D, Zamyatina A, De Castro C, Molinaro A. Lipopolysaccharide lipid A: a promising molecule for new immunity-based therapies and antibiotics. Pharmacol Ther. 2022;230:107970. doi: 10.1016/j.pharmthera.2021.107970.
   PubMed Web of Science ®Google Scholar
• Wong Y, Sethu C, Louafi F, Hossain P. Lipopolysaccharide regulation of toll-like receptor-4 and matrix metalloprotease-9 in human primary corneal fibroblasts. Invest Ophthalmol Vis Sci. 2011;52(5):2796–2803. doi: 10.1167/iovs.10-5459.
   PubMed Web of Science ®Google Scholar
• Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2005;46(1):114–120. doi: 10.1167/iovs.04-0922.
   PubMed Web of Science ®Google Scholar
• Pearlman E, Sun Y, Roy S, Karmakar M, Hise AG, Szczotka-Flynn L, Ghannoum M, Chinnery HR, McMenamin PG, Rietsch A. Host defense at the ocular surface. Int Rev Immunol. 2013;32(1):4–18. doi: 10.3109/08830185.2012.749400.
   PubMed Web of Science ®Google Scholar
• Song PI, Abraham TA, Park Y, Zivony AS, Harten B, Edelhauser HF, Ward SL, Armstrong CA, Ansel JC. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Investig Ophthalmol Vis Sci. 2001;42(12):2867–2877.
   PubMed Web of Science ®Google Scholar
• Johannessen M, Askarian F, Sangvik M, Sollid JE. Bacterial interference with canonical NFκB signalling. Microbiology. 2013;159(Pt 10):2001–2013. doi: 10.1099/mic.0.069369-0.
   PubMedGoogle Scholar
• Johnson AC, Heinzel FP, Diaconu E, Sun Y, Hise AG, Golenbock D, Lass JH, Pearlman E. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci. 2005;46(2):589–595. doi: 10.1167/iovs.04-1077.
   PubMed Web of Science ®Google Scholar
• Singh RB, Das S, Chodosh J, Sharma N, Zegans ME, Kowalski RP, Jhanji V. Paradox of complex diversity: challenges in the diagnosis and management of bacterial keratitis. Prog Retin Eye Res. 2022;88:101028. doi: 10.1016/j.preteyeres.2021.101028.
   PubMed Web of Science ®Google Scholar
• Bagga B, Sharma S, Ahirwar LK, Sheba E, Vaddavalli PK, Mishra DK. Clinical outcomes of rose bengal mediated photodynamic antimicrobial therapy on fungal keratitis with their microbiological and pathological correlation. Curr Eye Res. 2022;47(7):987–994. doi: 10.1080/02713683.2022.2058019.
   PubMed Web of Science ®Google Scholar
• Martinez JD, Naranjo A, Amescua G, Dubovy SR, Arboleda A, Durkee H, Aguilar MC, Flynn HW, Miller D, Parel JM. Human corneal changes after rose bengal photodynamic antimicrobial therapy for treatment of fungal keratitis. Cornea. 2018;37(10):e46–e48. doi: 10.1097/ICO.0000000000001701.
   PubMed Web of Science ®Google Scholar
• Halili F, Arboleda A, Durkee H, Taneja M, Miller D, Alawa KA, Aguilar MC, Amescua G, Flynn HW, Parel JM. Rose bengal- and riboflavin-mediated photodynamic therapy to inhibit methicillin-resistant Staphylococcus aureus keratitis isolates. Am J Ophthalmol. 2016;166:194–202. doi: 10.1016/j.ajo.2016.03.014.
   PubMed Web of Science ®Google Scholar
• Berryhill BL, Kader R, Kane B, Birk DE, Feng J, Hassell JR. Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Investig Ophthalmol Vis Sci. 2002;43(11):3416–3421.
   PubMed Web of Science ®Google Scholar
• Foster JW, Gouveia RM, Connon CJ. Low-glucose enhances keratocyte-characteristic phenotype from corneal stromal cells in serum-free conditions. Sci Rep. 2015;5(1):10839. doi: 10.1038/srep10839.
   PubMedGoogle Scholar
• Berger T, Szentmáry N, Chai N, Flockerzi E, Daas L, Stachon T, Seitz B. In vitro expression analysis of cytokines and ROS-related genes in human corneal fibroblasts and keratocytes of healthy and keratoconus corneas. Ocul Immunol Inflamm. 2023;1–10. doi: 10.1080/09273948.2023.2176325.
   Google Scholar
• Chai N, Stachon T, Nastaranpour M, Li Z, Seitz B, Ulrich M, Langenbucher A, Szentmáry N. Assessment of rose bengal photodynamic therapy on viability and proliferation of human keratolimbal epithelial and stromal cells in vitro. Klin Monbl Augenheilkd. 2023. doi: 10.1055/a-2038-8899.
   Google Scholar
• Kimura K, Orita T, Nomi N, Fujitsu Y, Nishida T, Sonoda KH. Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I: c), or zymosan. Exp Eye Res. 2012;96(1):157–162. doi: 10.1016/j.exer.2011.10.015.
   PubMed Web of Science ®Google Scholar
• Cherfan D, Verter EE, Melki S, Gisel TE, Doyle FJ, Scarcelli G, Yun SH, Redmond RW, Kochevar IE. Collagen cross-linking using rose bengal and green light to increase corneal stiffness. Invest Ophthalmol Vis Sci. 2013;54(5):3426–3433. doi: 10.1167/iovs.12-11509.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66(1):97–103. doi: 10.1006/exer.1997.0410.
   PubMed Web of Science ®Google Scholar
• Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, Amescua G, Yoo SH, Parel JM. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol. 2014;158(1):64–70.e2. doi: 10.1016/j.ajo.2014.04.007.
   PubMed Web of Science ®Google Scholar
• Gumus K. A new alternative to riboflavin/ultraviolet-a: collagen cross-linking with rose bengal/green light. Invest Ophthalmol Vis Sci. 2016;57(3):1002. doi: 10.1167/iovs.16-19319.
   PubMed Web of Science ®Google Scholar
• Naranjo A, Pelaez D, Arrieta E, Salero-Coca E, Martinez JD, Sabater AL, Amescua G, Parel JM. Cellular and molecular assessment of rose bengal photodynamic antimicrobial therapy on keratocytes, corneal endothelium and limbal stem cell niche. Exp Eye Res. 2019;188(May):107808. doi: 10.1016/j.exer.2019.107808.
   PubMedGoogle Scholar
• Martinez JD, Arrieta E, Naranjo A, Monsalve P, Mintz KJ, Peterson J, Arboleda A, Durkee H, Aguilar MC, Pelaez D, et al. Rose bengal photodynamic antimicrobial therapy: a pilot safety study. Cornea. 2021;40(8):1036–1043. doi: 10.1097/ICO.0000000000002717.
   PubMed Web of Science ®Google Scholar
• Durkee H, Arboleda A, Aguilar MC, Martinez JD, Alawa KA, Relhan N, Maestre-Mesa J, Amescua G, Miller D, Parel JM. Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates. Lasers Med Sci. 2020;35(4):861–866. doi: 10.1007/s10103-019-02871-9.
   PubMed Web of Science ®Google Scholar
• Demidova TN, Hamblin MR. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother. 2005;49(6):2329–2335. doi: 10.1128/AAC.49.6.2329-2335.2005.
   PubMed Web of Science ®Google Scholar
• Gao R, Yan M, Chen M, Hayes S, Meek KM, He H, Chen X, Xu W, Yan S, Huang Y, et al. The impact of different rose bengal formulations on corneal thickness and the efficacy of rose bengal/green light corneal cross-linking in the rabbit eye. J Refract Surg. 2022;38(7):450–458. doi: 10.3928/1081597X-20220601-03.
   PubMed Web of Science ®Google Scholar
• Fukuda K. Corneal fibroblasts: function and markers. Exp Eye Res. 2020;200(September):108229. doi: 10.1016/j.exer.2020.108229.
   PubMedGoogle Scholar
• Fukuda K, Kumagai N, Yamamoto K, Fujitsu Y, Chikamoto N, Nishida T. Potentiation of lipopolysaccharide-induced chemokine and adhesion molecule expression in corneal fibroblasts by soluble CD14 or LPS-binding protein. Invest Ophthalmol Vis Sci. 2005;46(9):3095–3101. doi: 10.1167/iovs.04-1365.
   PubMed Web of Science ®Google Scholar
• Ghasemi H. Roles of IL-6 in ocular inflammation: a review. Ocul Immunol Inflamm. 2018;26(1):37–50. doi: 10.1080/09273948.2016.1277247.
   PubMed Web of Science ®Google Scholar
• Chai N, Stachon T, Berger T, Li Z, Seitz B, Langenbucher A, Szentmáry N. Short-term effect of rose bengal photodynamic therapy (RB-PDT) on collagen I, collagen V, NF-κB, LOX, TGF-β and IL-6 expression of human corneal fibroblasts, in vitro. Curr Eye Res. 2023;49(2):150–157. doi: 10.1080/02713683.2023.2276057.
   Web of Science ®Google Scholar
• Cole N, Bao S, Stapleton F, Thakur A, Husband AJ, Beagley KW, Willcox MDP. Pseudomonas aeruginosa keratitis in IL-6-deficient mice. Int Arch Allergy Immunol. 2003;130(2):165–172. doi: 10.1159/000069006.
   PubMed Web of Science ®Google Scholar
• Hume EBH, Cole N, Garthwaite LL, Khan S, Willcox MDP. A protective role for IL-6 in staphylococcal microbial keratitis. Invest Ophthalmol Vis Sci. 2006;47(11):4926–4930. doi: 10.1167/iovs.06-0340.
   PubMed Web of Science ®Google Scholar
• Peng L, Zhong J, Xiao Y, Wang B, Li S, Deng Y, He D, Yuan J. Therapeutic effects of an anti-IL-6 antibody in fungal keratitis: macrophage inhibition and T cell subset regulation. Int Immunopharmacol. 2020;85(June):106649. doi: 10.1016/j.intimp.2020.106649.
   PubMedGoogle Scholar
• Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14(6):705–714. doi: 10.1016/s1074-7613(01)00151-0.
   PubMed Web of Science ®Google Scholar
• Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci. 2002;43(3):737–743.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18(18):2195–2224. doi: 10.1101/gad.1228704.
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-B pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi: 10.1101/cshperspect.a001651.
   PubMed Web of Science ®Google Scholar
• Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2(9):717–726. doi: 10.1038/nrd1177.
   PubMed Web of Science ®Google Scholar
• Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754(1–2):253–262. doi: 10.1016/j.bbapap.2005.08.017.
   PubMed Web of Science ®Google Scholar
• Symons A, Beinke S, Ley SC. MAP kinase kinase kinases and innate immunity. Trends Immunol. 2006;27(1):40–48. doi: 10.1016/j.it.2005.11.007.
   PubMed Web of Science ®Google Scholar
• Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13(9):679–692. doi: 10.1038/nri3495.
   PubMed Web of Science ®Google Scholar
• Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 1999;18(49):6853–6866. doi: 10.1038/sj.onc.1203239.
   PubMed Web of Science ®Google Scholar
• Awasthi A, Raju MB, Rahman MA. Current insights of inhibitors of p38 mitogen-activated protein kinase in inflammation. Med Chem. 2021;17(6):555–575. doi: 10.2174/1573406416666200227122849.
   PubMed Web of Science ®Google Scholar
• Hua X, Chi W, Su L, Li J, Zhang Z, Yuan X. ROS-induced oxidative injury involved in pathogenesis of fungal keratitis via p38 MAPK activation. Sci Rep. 2017;7(1):10421. doi: 10.1038/s41598-017-09636-w.
   PubMedGoogle Scholar
• Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011;21(1):103–115. doi: 10.1038/cr.2010.178.
   PubMed Web of Science ®Google Scholar
• Yao M, Gu C, Doyle FJ, Zhu H, Redmond RW, Kochevar IE. Why is rose bengal more phototoxic to fibroblasts in vitro than in vivo? Photochem Photobiol. 2014;90(2):297–305. doi: 10.1111/php.12215.
   PubMed Web of Science ®Google Scholar